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Characterization of Disease-Related Covariance Topographies
with SSMPCA Toolbox: Effects of Spatial Normalization and PET
Scanners
Shichun Peng†, Yilong Ma*, Phoebe G Spetsieris†, Paul Mattis, Andrew Feigin, Vijay
Dhawan, and David Eidelberg
Center for Neurosciences The Feinstein Institute for Medical Research North Shore-Long Island
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Abstract
NIH-PA Author Manuscript

In order to generate imaging biomarkers from disease-specific brain networks, we have
implemented a general toolbox to rapidly perform scaled subprofile modeling (SSM) based on
principal component analysis (PCA) on brain images of patients and normals. This SSMPCA
toolbox can define spatial covariance patterns whose expression in individual subjects can
discriminate patients from controls or predict behavioral measures. The technique may depend on
differences in spatial normalization algorithms and brain imaging systems. We have evaluated the
reproducibility of characteristic metabolic patterns generated by SSMPCA in patients with
Parkinson's disease (PD).
We used [18F]fluorodeoxyglucose PET scans from PD patients and normal controls. Motor-related
(PDRP) and cognition-related (PDCP) metabolic patterns were derived from images spatially
normalized using four versions of SPM software (spm99, spm2, spm5 and spm8). Differences
between these patterns and subject scores were compared across multiple independent groups of
patients and control subjects. These patterns and subject scores were highly reproducible with
different normalization programs in terms of disease discrimination and cognitive correlation.
Subject scores were also comparable in PD patients imaged across multiple PET scanners.

NIH-PA Author Manuscript

Our findings confirm a very high degree of consistency among brain networks and their clinical
correlates in PD using images normalized in four different SPM platforms. SSMPCA toolbox can
be used reliably for generating disease-specific imaging biomarkers despite the continued
evolution of image preprocessing software in the neuroimaging community. Network expressions
can be quantified in individual patients independent of different physical characteristics of PET
cameras.
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Overall Description of the Procedure
It is often a challenge to diagnose and assess neurological disorders on clinical criteria alone.
Functional brain imaging methods can provide an objective basis for discriminating patients
from controls and for differential diagnosis of clinically similar neuropsychiatric syndromes
(Habeck et al., 2008; Spetsieris et al., 2009; Tang et al., 2010). Likewise, statistical mapping
approaches can be used to assess disease progression and the effects of novel interventions
on resting brain function (Eidelberg, 2009; Feigin et al., 2007a; Hirano et al., 2008). In
general, two analytical techniques have been used to identify and validate disease-related
biomarkers in functional and anatomical neuroimaging data. Mass-univariate general linear
models [e.g. statistical parametric mapping (SPM)] provide a widely used approach to
delineate regional abnormalities that are specific to a given illness. By contrast, multivariate
approaches based on spatial covariance mapping [e.g., scaled subprofile model (SSM)/
principal component analysis (PCA)] provide a reliable means to characterize diseaserelated network abnormalities and quantify these changes in individual subjects.
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We have implemented a general toolbox (The software freely available to the neuroimaging
community at http://www.fil.ion.ucl.ac.uk/spm/ext/) to rapidly perform SSM/PCA operation
on brain images from patients and normals. The underlying algorithm and its assumptions
were introduced in the early 1990's for use in volume-of-interest (VOI) data (Alexander and
Moeller, 1994; Eidelberg et al., 1994; Moeller and Strother, 1991; Petersson et al., 1999)
and was subsequently extended for voxel-level whole brain analysis (Asanuma et al., 2005;
Habeck et al., 2008; Ma et al., 2007; Moeller et al., 1999). This SSMPCA toolbox was
developed to provide automated voxel-wise computations with an improved user-interface,
and optimized efficiency for general applications. It can identify characteristic abnormal
covariance patterns from principal components whose expression in individual subjects (i.e.,
subject scores) either discriminate patients from controls or correlate with independent
descriptors of disease severity or behavior performance. In addition, an inverse algorithm
called topographic profiling rating (TPR) has been devised to prospectively quantify
expressions of a given covariance pattern for new subjects on a single case basis.
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Spatial covariance analysis with SSMPCA toolbox has been used extensively in the study of
Parkinson's disease (PD) and other neurodegenerative disorders (Eidelberg, 2009; Ma et al.,
2009; Poston and Eidelberg, 2009; Tang et al., 2010). We have found with
[18F]fluorodeoxyglucose (FDG) PET that PD is associated with two specific covariance
patterns for motor and cognitive symptoms. Subject scores of the PD motor-related pattern
(PDRP) have been shown to correlate with independent measures of disease severity, with
changes in PDRP expression correlating with clinical outcome following antiparkinsonian
interventions (Asanuma et al., 2006; Fukuda et al., 2001; Poston and Eidelberg, 2009). By
contrast, subject scores for the PD cognition-related pattern (PDCP) have been found to
correlate with the degree of cognitive impairment noted in these patients (Eidelberg, 2009;
Huang et al., 2008; Huang et al., 2007a). Furthermore, characteristic metabolic covariance
patterns have also been identified to aid diagnosis of atypical (Eckert et al., 2008; Tang et
al., 2010) and tremor-related (Mure et al., 2011) parkinsonism in a clinical setting.
One key prerequisite for univariate or multivariate brain mapping studies at the voxel level
is spatial registration and normalization of individual images. This is usually performed
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using commonly available computing tools implemented in SPM software (Friston, 2007).
Over the last decade this software has evolved steadily (four officially released versions
from spm99 to spm8) to provide more powerful solutions for inferential statistics. In
particular, optimized algorithms are incorporated into these routines to improve the accuracy
of image preprocessing. Parallel to these developments in the neuroimaging field, SSMPCA
can be run using different preprocessing methods, which are likely to introduce a degree of
inconsistency into the results. Thus, it may be difficult to compare or interpret the results of
SSMPCA without knowing the comparability of covariance patterns using these different
image preprocessing tools. Network expressions may also depend on differences in PET
cameras and image reconstruction algorithms given the variation of imaging systems among
many nuclear medicine facilities.
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In this study, we evaluated the performance of the SSMPCA toolbox in generating
characteristic disease-specific patterns with the use of different versions of the SPM
program. This was based on both PDRP and PDCP which have been generated and validated
extensively with spm99 (Asanuma et al., 2006; Hirano et al., 2008; Huang et al., 2007a;
Huang et al., 2007b; Ma et al., 2007; Mattis et al., 2011; Spetsieris and Eidelberg, 2011;
Trost et al., 2006). We observed an error of 5-7 % in the diagnostic accuracy when
evaluating these brain networks with images normalized using newer versions of SPM
software. By preprocessing FDG PET images with different spatial normalization
algorithms, we assessed the stability of metabolic covariance patterns in discriminating
patients from controls and in correlating with behavioral measures in independent
populations. The reproducibility of subject scores for these patterns was also assessed using
images from different PET scanners and SPM normalization programs.

Summary of the Materials and Equipment Used
The SSMPCA toolbox was implemented in MATLAB (Mathworks, Natick, MA, USA), a
common software platform used by researchers in the neuroimaging field. Brain images
from the scanner database are extracted into DICOM format and transformed into standard
Analyze or NIfTI-1 file format. Imaging volumes of all subjects are then mapped to the
same physical space by spatial transformation to a standardized brain template. This
normalization procedure allows automated data-driven processing in both VOI- and voxelbased analyses over the whole brain. User-defined threshold criteria, smoothing and
masking constraints are also applied uniformly over all image data in order to enhance
signal-to-noise ratio prior to statistical analysis.
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For network analysis and diagnosis, we use an implementation of SSM in conjunction with
PCA that includes automated TPR diagnostic tools (Ma et al., 2007; Spetsieris et al., 2006).
SSMPCA can be applied to brain images for a combined group of patients and controls or a
single subject group (Fig. 1). Each input VOI dataset or spatially normalized brain image
undergoes a natural log-transformation if imaging data have positive values and
multiplicative variability (e.g. PET). In contrast, this transformation is not suitable if
imaging data have negative values or additive variability (e.g. fMRI). The resulting data
from all subjects are then entered into a PCA after applying an offset to remove subject- and
voxel-specific mean effects. It is this two-step centering procedure that ensures that the
estimated topographic pattern is a direct measure of the spatial covariation among widely
distributed brain regions. Although the log-transformation is not always essential, the use of
double-centered log-transformed PCA (Joliffe, 2002) is known to minimize the effect of any
subject- and/or group-dependent differences in global brain function on pattern topography
[c.f.(Spetsieris and Eidelberg, 2011)]. SSM analysis outputs a set of principal components
(PCs) along with the fraction of the variance accounted for (VAF) by each PC. This
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operation also generates subject scores that reflect the degree to which a subject expresses
the associated network topology in each PC.
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The PCs resulting from a single SSM/PCA run represent a set of regional vectors or voxel
maps of Group Invariant Subprofile (GIS) that may result from functional abnormality in
relevant brain disorders. Each GIS pattern consists of voxels with both positive and negative
values that are termed region weights (Eidelberg, 2009; Ma et al., 2009). The values of the
region weight measure the degree and direction of regional covariance and the relative
contribution to a GIS pattern by each voxel. Positive voxel weights indicate that as pattern
expression increases, relative metabolic activity in the positively weighted voxels increases
as well. Likewise, negative voxel weights indicate decreases in relative local metabolic
activity with increasing pattern expression.
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To obtain a clinically relevant covariance pattern it is necessary to examine a subset of PCs
(e.g. 1-6) with the total voxel-subject variance exceeding 50 %. Subject scores for individual
PCs can be linearly combined by logistical regression to identify the optimal combination
that best separates patients from controls or predicts behavior correlates in a single subject
group. Consequently, a disease-specific covariance pattern can be defined by either a single
PC or a linear combination of these PCs using the same parameters determined by the
logistic regression. In the forward application, subject scores were determined by TPR from
the dot product between the covariance pattern and individual brain images with or without
the natural log-transformation. Hence, subjects will have higher scores for a pattern if their
brain images contain more regions with concomitantly more increased and/or more
decreased relative brain activity. Likewise, subjects will have lower scores following the
restoration of regional brain function.
To derive a robust covariance pattern one has to assess the reliability of the region-weight
that is significantly different from zero at each voxel. The SSMPCA toolbox uses a
bootstrapping algorithm to estimate the reliability of each covariance pattern as described
elsewhere (Habeck et al., 2003). In this module, PCA procedure is repeated iteratively for a
large number of iterations (e.g. 500-1000) by resampling the original sets of brain images
with replacement. A three-dimensional (3D) map of inverse coefficient of variation (ICV) is
produced on a voxel basis by dividing the region-weight of the original covariance pattern
by the standard deviation of covariance patterns generated from all iterations in the
bootstrapping. This map allows the user to define a statistic for measuring the reliability by
selecting a z-threshold for both positive and negative region-weights of a particular
covariance pattern.

NIH-PA Author Manuscript

Step-by-step Description of the Research Protocol
In this study we used brain scans of cerebral glucose metabolism from several cohorts of
patients and normal controls for pattern derivation and prospective validation. FDG PET
images were acquired in 3D mode using a GE Advance tomograph (GE Medical Systems,
Milwaukee, WI, USA) at North Shore University Hospital. On a fast since the night before,
all subjects remained at rest in a quiet and dimly-lit room during radiotracer uptake and
imaging. The procedure involved taking one single blood sample at 20 min post-injection,
followed by a sequential transmission and emission scanning protocol (Ma et al., 2007).
Table I provides the demographic and clinical information of all subjects. For studies on the
motor-related PDRP network, two independent cohorts were created randomly from the
FDG PET images in 33 PD patients and 33 age-matched controls that were originally used
to generate the PDRP in the test-retest study (Ma et al., 2007). The patients had a total motor
score of 31.3 ± 16.4 (mean ± SD) as evaluated by the Unified Parkinson's Disease Rating
Scale (UPDRS). For PDRP identification, we used images in the first cohort of 20 PD
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patients (age 55 ± 5 yr; Hoehn and Yahr [H&Y] stages 2-4) and 20 normal controls (age 55
± 9 yr). For prospective validation, subject scores were determined in the second cohort of
13 PD patients (age 61 ± 11 yr; H&Y stages 2-4) and 13 normal controls (age 55 ± 19 yr).
There were no significant differences in age (ANOVA: F3,62 = 1.11, p = 0.35) among these
four subject groups.
To derive the cognition-related PDCP network, we used FDG scans from a single group of
15 non-demented PD patients (age 59 ± 10 yr; H&Y stages 2-4; MMSE 28.2 ± 2.1)(Huang
et al., 2007a). Fifteen age-matched healthy subjects (age 57 ± 13 yr) served as normal
controls. Furthermore, an independent sample of 15 PD patients (age 62 ± 5 yr; H&Y stages
2-4; MMSE 28.2 ± 1.6) was used for prospective validation of this pattern (Huang et al.,
2008). Age did not differ across these three subject groups (ANOVA: F2,42 = 1.16, p =
0.32). All patients with PD were assessed with UPDRS and a battery of neuropsychology
tests on their cognitive performance as described previously (Huang et al., 2008; Huang et
al., 2007a). Patients in the validation sample had been diagnosed to have single domain mild
cognitive impairment (MCI) but were otherwise similar to those in the derivation sample (p
≥ 0.23; Student's t-test; Table I). Ethical permission for this study had been given by the
local Institutional Review Board. Written informed consent had been obtained from each
subject with detailed explanation of the procedures and in accordance with the Code of
Ethics of the World Medical Association (Declaration of Helsinki).
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All images were preprocessed using four different versions (spm99, spm2, spm5 and spm8)
of SPM software (Wellcome Department of Imaging Neuroscience, Institute of Neurology,
London, UK; http://www.fil.ion.ucl.ac.uk/spm). Individual images were spatially
normalized into Talairach brain space. This standard anatomical space was defined by a
series of image-modality specific brain templates. The normalization used linear and nonlinear registration algorithms in each of four SPM versions (Ashburner and Friston, 1999;
Ashburner et al., 1997). The default registration was not regularized sufficiently in spm99.
The algorithms were more refined from spm2 onwards, with increased regularization and
optimization in the iterative registration algorithm. These algorithms perform better in
reducing the effect of potential brain atrophy (e.g. in the PDCP network) on the
normalization accuracy compared to the previous method implemented in spm99. The
normalized images were then smoothened by a Gaussian 10mm filter over a 3D space to
increase signal to noise ratio before statistical analysis.
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PDRP and PDRP topographies were generated from images spatially normalized by each
version of SPM software. Differences across four versions of PDRP or PDCP were
separately assessed by visual inspection and by quantitative pairwise comparison. For
qualitative inspection, the four versions of each pattern were overlaid onto a standard MRI
brain template on three orthogonal views using the same thresholds. For quantitative
analysis, the four versions of each pattern were compared by computing the region-weights
in a set of 30 VOIs covering the whole brain, including only voxels ≥ ±80 % of the maxima
within each VOI. The comparisons were also made voxelwise to evaluate topographic
patterns more accurately. In addition, subject scores for PDRP/PDCP were computed for the
images in the validation sample. All subject scores were z-transformed individually by
subtracting control mean and dividing by pooled standard deviation in the original
derivation sample. This made the mean value of the derivation controls equal to zero and
ensured the comparability of subject scores across different populations.

Multicenter Reproducibility of Network Expressions
To assess the reproducibility of PDRP/PDCP scores across multiple PET scanners, we used
FDG PET scans acquired at baseline from 23 non-demented patients with advanced PD who
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belonged originally to the sham group in a randomized double-blind gene therapy trial
(Lewitt et al., 2011). All subjects (age 61 ± 7 yr; H&Y stages 2-4; UPDRS 39.0 ± 8.7) were
scanned over 35-45 min post-injection in five medical centers in the USA with five different
PET cameras (Suppl. Table I). These cameras included four PET alone machines and one
PET/CT scanner made by two major vendors, with a 3D resolution of 4-6 mm at the center
and 5-7 mm at 10 cm from the center. PET images were reconstructed with one of four
different methods commonly used at each site. Subject scores of PDRP/PDCP networks
were then determined as described above.

Statistical Analysis

NIH-PA Author Manuscript

Data analyses for PDRP and PDCP networks were performed separately and in parallel. All
comparisons were made in reference to the results from spm99-processed images which
have been validated rigorously as noted in the introduction. For the four versions of each
pattern, region weights were correlated pairwise using both VOI- and voxel-based
regression analyses. Between-group differences in subject scores for each version of the
PDRP were evaluated with two-sample t-tests and receiver operating characteristic (ROC)
analyses in both cohorts of PD patients and healthy controls. To assess the single-case
diagnostic power of PDRP score from spm99-normalized images, an optimal threshold was
chosen to give high sensitivity and specificity of 95 % in the derivation cohort and then
applied to the validation cohort. In each cohort, the reproducibility of diagnostic accuracy
was further tested by subject scores from the other three versions of the PDRP using the
same optimal threshold chosen above. In addition, subject scores for each version of the
PDCP were correlated with age, UPDRS motor ratings, and neuropsychological measures in
patients. Within each group of patients and controls, subject scores were also correlated
among the four versions of PDRP or PDCP network. All statistical computations were
performed using SPSS software (SPSS Inc., Chicago, IL, USA) running on PCs and were
considered significant with P < 0.05.

Results
PDRP
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The PDRP topography was identified as the first PC that accounted for at least 18.3%
subject × voxel variance in the four derivation analyses (Fig. 2), each using a different
version of the SPM normalization software. Subject scores for each of the four resulting
versions were elevated in the PD patients relative to the healthy controls (p < 0.0001). These
four PDRPs were very similar in terms of metabolic topographies of increased and
decreased regional covariation (Fig. 3) and reliable at p < 0.005 according to the
bootstrapping estimation (Suppl. Fig. 1A). The major results for the four PDRP versions
were summarized in Table II. Region-weights of these patterns from images normalized by
spm2, spm5 and spm8 were highly intercorrelated (p < 0.0001) with those from spm99 (R ≥
0.998; Suppl. Fig. 2) and almost identical among themselves (R = 1.0).
The subject scores for each version of the four PDRPs were significantly higher in the
patients versus the controls in the two separate cohorts (p < 0.0001; Fig. 4). These scores
exhibited excellent discriminating accuracy in the original derivation (AUC ≥ 0.984, 95%
confidence of interval [CI] = 0.956 – 1.012) and the prospective validation (AUC ≥ 0.959,
95% CI = 0.892 – 1.027) cohorts. For single-case diagnosis, the specificity and sensitivity
were excellent in the derivation cohort, but slightly better for the spm99-processed images
than for the other three versions. In the validation cohort, despite high specificity overall, the
sensitivity was also better for the former than for the latter. PDRP scores from four SPMnormalization programs were highly inter-correlated (p < 0.0001; Suppl. Fig. 2) for the
controls and the patients in the derivation (R ≥ 0.971) and the validation (R ≥ 0.966) cohorts.
Hum Brain Mapp. Author manuscript; available in PMC 2015 May 01.
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PDCP was identified in separate analyses in which subject differences in the expression of
each PC were correlated with the behavioral measures (Huang et al., 2007a). The PDCP
topography was determined as the second PC (accounting for at least 19.3% of subject ×
voxel variance; Fig. 2) using images from each version of the SPM programs. Subject scores
for each of the resulting PDCPs correlated (p < 0.01) with the degree of cognitive
impairment measured by California verbal learning test (CVLT). These four PDCPs were
also highly similar (Fig. 5) and reliable at p < 0.005 according to the bootstrapping
estimation (Suppl. Fig. 1B). The major results for the four PDCPs were summarized in
Table III. Region-weights of the PDCPs from images normalized by spm2, spm5 and spm8
were also highly intercorrelated (p < 0.0001) with those from spm99 (R ≥ 0.968; Suppl. Fig.
2) and almost identical among themselves (R = 1.0).
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Subject scores from each version of the four PDCPs correlated negatively with individual
values of CVLT in the original derivation (R ≤ -0.645, p < 0.01; Suppl. Fig. 3 and
prospective validation (R ≤-0.503, p = 0.056) patients with PD. The correlations in the
combined sample were similar (R≤ -0.632. p < 0.001; Fig. 6) with comparable magnitudes
among four versions of the PDCP. In other words, a higher PDCP score predicted a
worsening ability in verbal learning and memory. However, the same subject scores did not
correlate with UPDRS motor scores in each of the two patient groups (p ≥ 0.83). In addition,
PDCP scores from the four SPM-normalization programs were highly correlated (R ≥ 0.948,
p < 0.0001; Suppl. Fig. 2) in the derivation and validation groups.
Multicenter Reproducibility of Network Expressions
Network scores of PD patients in Sites A (the Feinstein Institute), B, C, D, and E were
presented in Table IV and Fig. 7. UPDRS motor ratings or PDRP scores were comparable
for the patients across the five Sites, with no differences between the 10 subjects from Site A
and the 13 subjects from all other Sites (p > 0.32). PDCP network scores were similar to
those for the PDRP network scores. PDRP/PDCP scores were also analogous between
spm99- and spm5-processed images for individual subjects at each of the five Sites (Suppl.
Fig. 4).

Discussion
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Parkinson's disease results from progressive losses of dopaminergic neurons in the
nigrostriatal system, as well as non-dopaminergic neurons of serotonergic and
norepinephrinergic origins in the related neural pathways. Cortical brain atrophy and Lewy
body deposition may also underlie cognitive dysfunction. It is this complex neuropathology
that leads ultimately to widespread motor symptoms and cognitive impairment in PD
(Caballol et al., 2007). We have established that motor and cognitive dysfunction in PD are
associated with specific spatial covariance patterns involving distinct metabolic
abnormalities in subcortico-cortical pathways (Eidelberg, 2009; Huang et al., 2007a; Lozza
et al., 2004; Ma et al., 2007). Both patterns included large areas not normally associated
with PD, reflecting the nature of covariance analysis for revealing distal brain regions within
a widely distributed network. Widespread cortical abnormalities in metabolism and
perfusion have also been described with PET and SPECT using other analysis methods
(Bohnen et al., 2011; Hsu et al., 2007). Indeed, PDRP expression correlated with the
increasing severity of motor symptoms and was modulated with successful pharmacologic
and stereotaxic surgical interventions for PD (Feigin et al., 2001; Fukuda et al., 2001). By
contrast, PDCP expression correlated with independent measures of cognitive dysfunction in
PD and did not exhibit such characteristics seen in the PDRP network (Hirano et al., 2008;
Huang et al., 2007b). PDRP and PDCP expressions in individual patients may be useful in
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selecting candidates for clinical trials and track their response and prognosis over long-term
follow-up.
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We have previously shown the excellent reliability of these two characteristic patterns
within and between imaging sessions. By using functional brain images preprocessed with
spm99, we validated PDRP/PDCP expressions as disease-related biomarkers in prospective
patient cohorts scanned at rest with FDG and H 152O PET techniques (Huang et al., 2007a;
Ma et al., 2007). Subject scores obtained from regional cerebral glucose metabolism
(rCMRglc) and blood flow (rCBF) data in the same cohort of patients and controls were
highly comparable for both PDRP and PDCP. We also demonstrated the stability of these
measures in test–retest studies of patients scanned at different disease stages in the untreated
condition and during pharmacological or neurosurgical interventions. This information is
useful in the design of interventional imaging studies of novel therapies for PD and related
neurodegenerative disorders.
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We have now demonstrated that the results obtained from FDG PET images spatially
normalized by spm2, spm5 and spm8 are highly consistent with those in the previous studies
with spm99. Indeed, the motor-related PDRPs were strongly correlated among four versions
of SPM program in terms of the region-weights assessed over the whole brain (R > 0.98;
Table II). The topography of these PDRP networks was very similar to that from
multivariate independent component analysis of SPECT brain perfusion data (Hsu et al.,
2007). PDRP expression reliably distinguished PD patients from normal controls with a high
degree of accuracy in two independent cohorts and across four versions of SPM software.
Nevertheless, there was a small decline in the discrimination power in the validation cohort
due to the reduced number of subjects. Furthermore, subject scores in PD patients from
spm99-normalized images were slightly higher than those from other versions of SPM
program, consistent with the marginally better discrimination power in the corresponding
PDRP. Subject scores of all PDRPs were strongly correlated in the two independent groups
of PD patients or normal controls.
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The determination of disease-specific patterns with SSMPCA may depend on the selection
of optimal PCs, sample size and image smoothing. We compared the distribution of subject
scores in the derivation of PDRP or PDCP with different sets of combinations of contiguous
PCs (1-2 until 1-6), using PET images normalized with both spm99 and spm5. For each
combination of PCs, the total VAF was comparable with subject scores in each group highly
correlated between the two versions of SPM (Suppl. Table II-III). The first PC consistently
gave the maximum group discrimination in subject scores. The second PC produced the
strongest behavioral correlation in the reference condition of spm99. Hence, the first/second
PC was used to define the PDRP/PDCP as described in this article. The effect of image
smoothing remains to be fully assessed.
The PDRP network reported here with 20 PD patients and 20 control subjects was very
similar to that derived from a large sample of patients and controls. Indeed, PDRP networks
generated from the whole groups of 33 PD patients and 33 controls also were highly
correlated (R ≥ 0.94; p < 0.0001) with the former in terms of the region-weights and subject
scores with spm99- or spm5-normalized images. Discrimination power was also comparable
among different groups of patients and controls. To test the effect of the sample size on
PDRP, a series of empirical studies were conducted by randomly selecting a smaller number
of subjects in the derivation sample. The results indicated that reliable variance patterns may
be identified with as few as 10 patients and 10 controls.
The cognition-related PDCP topographies were also highly reproducible among four
versions of SPM normalization program, with very strong pairwise correlations in the
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region-weights (R ≥ 0.94; Table III). The PDCP network was almost identical to the
topography obtained from another voxel-based multivariate analysis method using brainbehavior partial least squares (Mentis et al., 2002). PDCP expression reliably predicted
objective measures of cognitive dysfunction in two independent groups of PD patients
across four versions of SPM software. However, the predictive power of the PDCP score
was marginally better in spm99-normalized images than those preprocessed with other
versions of SPM in the 15 derivation patients. PDCP scores from the former were higher
(but not significantly) than those from the latter in both patient groups. Lower PDCP scores
in spm2-8 were attributed to the normalization methods which tend to minimize the spread
of hypometabolic brain regions (predominate in the PDCP). Consistent with a diagnosis of
MCI the validation sample had higher (non-significant) PDCP scores relative to the
derivation sample. Given that the behavioral correlations in the combined sample were
comparable in magnitudes and directionality with those in the derivation or validation
groups (Table III) the effects of sample size were also estimated empirically. These results
all showed high similarity among four versions of SPM normalization program, suggesting
that a sample size of 15 is adequate in such a network analysis.
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PDRP/PDCP topographies and subject scores were almost identical using FDG PET images
spatially normalized by spm2, spm5 and spm8, suggesting the very high degree of similarity
in the standard brain template and spatial normalization algorithms in these three latest
versions of SPM software. We noted that the PDRP was mostly symmetrical in terms of
abnormal relative regional metabolism reflecting bilateral motor symptoms in our PD
patients. In contrast, the relative cortical hypometabolism in the PDCP appears to be more
pronounced on the left hemisphere, attributed to the stringent threshold used to display the
pattern, although a left-sided dominance of cortical hypometabolism could not be excluded
in PD patients with verbal learning dysfunction.
We have demonstrated that network expressions in PD patients were highly comparable
across multiple PET scanners in the context of a multicenter clinical trial. PDRP/PDCP
scores in this sample did not differ from those in the derivation and validation patients
described above, in line with similar degrees of motor symptoms or cognitive dysfunction
among different cohorts of PD patients. Despite the small numbers of subjects available per
site this result agreed well with our recent study in which PD-related networks were found to
be reproducible in many multicenter studies using different PET cameras and reconstruction
algorithms (Niethammer and Eidelberg, 2012).
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The methods implemented in the SSMPCA toolbox have been applied to many
neurodegenerative disorders using a variety of multimodality brain imaging data at restingstate. In addition to many studies that employ FDG and H 152O PET imaging (Hirano et al.,
2008; Ma et al., 2007), PD-related brain networks can be derived or quantified by using
rCBF data acquired by SPECT (Eckert et al., 2007; Feigin et al., 2002) and perfusionweighted MRI (Ma et al., 2010). We also revealed a spatial covariance pattern related with
MPTP-induced parkinsonism using FDG PET in macaques (Ma et al., 2008; Ma et al.,
2012). This pattern was topographically similar to the PDRP network in patients and was
modulated by experimental therapy.
Specific spatial covariance patterns were also reported in normal aging (Moeller et al., 1996;
Zuendorf et al., 2003), Huntington's disease (Feigin et al., 2007b), and torsion dystonia
(Asanuma et al., 2005; Trost et al., 2002) using FDG PET, and in patients with Alzheimer's
disease (AD) using rCMRglc or rCBF data from PET (Habeck et al., 2008; Kerrouche et al.,
2006; Scarmeas et al., 2004) as well as from the perfusion- weighted MRI (Asllani et al.,
2008). Furthermore, these multivariate techniques were useful in identifying structural
covariance patterns based on anatomical MRI data. These included atrophy-related regional
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covariance patterns associated with normal aging (Bergfield et al., 2010; Brickman et al.,
2008) and AD (Chen et al., 2004) in human subjects, along with the aging-related pattern in
the rhesus macaque (Alexander et al., 2008). Therefore SSMPCA provides a valuable
methodology for generating specific brain networks with both functional and anatomical
imaging markers.

Conclusion
PCA-based network analysis with SSMPCA toolbox can be used to identify disease-related
covariance patterns associated with motor and cognitive functioning. PDRP and PDCP brain
networks have been generated to describe the characteristic abnormal metabolism in PD
using FDG PET images spatially normalized by four different versions of SPM program
developed over the last decade. All results replicate our previous work independent of the
normalization algorithms implemented in different SPM software. Network expressions are
also reproducible in PD patients of similar clinical severity despite the use of different PET
cameras or image reconstruction methods. SSMPCA toolbox allows fast multivariate
statistical analysis of functional and anatomical brain images in a variety of
neurodegenerative disorders. Disease specific patterns may be used as imaging biomarkers
to enhance diagnostic accuracy and track disease progression, improve patient screening and
treatment evaluation in clinical trials.
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Fig. 1.

Flow chart for the multivariate covariance analysis with SSMPCA toolbox. A. Pattern
derivation: principal component analysis (PCA) can be performed on brain images for two
subject groups or one single group. Input data may be log-transformed and then offset to
remove subject-specific measures of global scaling factors and region-specific effects
termed group mean profile (GMP). PCA is done within a brain mask defined by the input
imaging data. Logistic regression is conducted on subject scalar factors for a subset of PCs
for optimizing the discrimination between the two subject groups or behavioral correlation
in the single subject group. B. Forward application: topographic profiling rating (TPR) can
be applied prospectively to brain images from any number of subject groups or conditions.
The computation is carried out using a brain mask and GMP either come from the original
sample for the PCA operation or defined by the user in the prospective sample of any new
population. Subject scores of each covariance pattern are usually transformed into z-scores
for prospective analysis.
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Fig. 2.

Eigenvalue distributions produced for the derivations of Parkinson's disease-related pattern
(PDRP) and Parkinson's disease cognitive pattern (PDCP) using FDG PET images
normalized by spm99, spm2, spm5 and spm8. Variance accounted for (VAF) was plotted for
each of major principal components from SSMPCA network analyses. Each of the PDRPs
was identified by the first PC (asterisk) from 20 PD patients and 20 age-matched normal
volunteers in the original derivation sample. Each of the PDCPs was identified by the
second PC (asterisk) from 15 non-demented PD patients with mild to moderate motor
symptoms in the original derivation sample. Asterisks denoted the optimal PC that gave rise
to the maximum group separation (PDRP) or behavioral correlation (PDCP).
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Fig. 3.

Comparisons of Parkinson's disease-related pattern (PDRP) from FDG PET images
normalized by spm99, spm2, spm5 and spm8. Each of the PDRPs was identified by network
analysis of FDG PET scans from 20 PD patients and 20 age-matched normal volunteers in
the original derivation sample. This covariance pattern was characterized by relative
pallidal, thalamic, sensorimotor, pontine, and cerebellar hypermetabolism, associated with
covarying metabolic decrements in the lateral premotor and posterior parietal areas. PDRP
expression (subject scores) for this pattern was significantly (p < 0.001) increased in the PD
patients relative to the normal control subjects. [The displays are on a standard singlesubject MRI brain template and represent voxels that contribute significantly (p < 0.005) to
the network based on a bootstrapping estimation algorithm. Red/blue colors indicate brain
regions with concurrently increased/decreased covariation between regional glucose
metabolism.]
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Disease differentiations by subject scores of the PDRP networks from FDG PET images
normalized by spm99 (A) and spm5 (B). In both cases, PDRP scores were elevated (p <
0.00001) in the 20 PD patients relative to the 20 controls in the original derivation sample.
This excellent disease discrimination is similar to that from subject scores computed
prospectively between the 13 PD patients and the 13 controls in the validation sample. The
dash-lines indicate the optimal threshold defined from PDRP scores in the derivation cohort
using spm99-normalized images. The performance figures by the subject scores of the PDRP
in both derivation sample and validation sample are highly equivalent between images
normalized by the four versions of SPM program (see text).
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Fig. 5.

Comparisons of Parkinson's disease cognitive pattern (PDCP) from FDG PET images
normalized by spm99, spm2, spm5 and spm8. Each of the PDCPs was identified by network
analysis of FDG PET scans from 15 non-demented PD patients with mild to moderate motor
symptoms in the original derivation sample. This covariance pattern was marked by bilateral
metabolic reductions in the rostral supplementary motor area (preSMA) and precuneus, the
dorsal premotor cortex, the inferior parietal lobule, as well as in the left prefrontal region,
covarying with relative metabolic increases in the cerebellar vermis and dentate nuclei.
Subject scores for this pattern correlated significantly (p < 0.01) with psychometric indices
of verbal learning performance. [The displays are on a standard single-subject MRI brain
template and represent voxels that contribute significantly (p < 0.01) to the network based
on a bootstrapping estimation algorithm. Red/blue colors indicate brain regions with
concurrently increased/decreased covariation between regional glucose metabolism.]
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Fig. 6.
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Behavioral correlations by subject scores of the PDCP networks from FDG PET images
normalized by spm99 (A) and spm5 (B). In both cases, subject scores were negatively
correlated with individual values of California Verbal Learning Test (CVLT) in the 15 PD
patients in the original derivation sample (closed circles) and in the 15 PD patients in the
validation sample (open circles). Each graph included a linear regression fit (solid line) and
95% confidence of intervals (dash lines) in the combined sample of 30 PD patients. The
performance figures by the subject scores of the PDCP in individual samples and in the
combined sample are highly equivalent between images normalized by the four versions of
SPM program (see text).
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Fig. 7.

Reproducibility of disease-related brain network expressions in PD patients using FDG
images acquired with five different PET scanners and normalized by spm99 and spm5. A.
UPDRS motor ratings in patients at each of the five participating sites. B: Subject scores of
the PDRP network. C: Subject scores of the PDCP network. Network scores for patients
from the Feinstein Institute (Site A) were similar to those from all other Sites (B, C, D and
E). Specific information on the PET scanner at each site is listed in Suppl. Table I. Network
scores were highly comparable among multiple PET cameras and image reconstruction
methods using different versions of SPM normalization program (see text).
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Clinical characteristics in patients with Parkinson's disease and normal controls
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Derivation Sample
Group

PD

Validation Sample

NC

PD

NC

PDRP
Number

20

20

13

13

Age (yr)

54.7 ± 4.9

55.1 ± 9.0

61.1 ± 10.6

54.9 ± 18.7

Number

15

-

15

15

Age (yr)

58.6 ± 9.5

-

62.1 ± 5.2

56.8 ± 9.5

UPDRS

31.3 ± 15.4

-

33.7 ± 16.3

-

MMSE

28.3 ± 2.1

-

28.2 ± 1.6

-

CVLT

35.0 ± 15.3

-

34.6 ± 9.5

-

Trails B

138.1 ± 63.9

-

134.0 ± 63.2

-

HVOT

19.2 ± 4.5

-

19.6 ± 4.5

-

PDCP
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All values are given as mean ± SD
UPDRS = Unified Parkinson's Disease Rating Scale
MMSE = Minimal Mental Status Examination
CVLT = California Verbal Learning Test
Trails B = Trail Making Test Part B
HVOT = Hooper Visual Organization Test
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Comparisons of PDRP network and subject scores with FDG PET images normalized by four versions of SPM
software
SPM99
VAF (%)
a

GIS weights

SPM2

SPM5

SPM8

18.33

19.43

19.46

19.61

1.000/1.000

0.998/0.987

0.998/0.986

0.998/0.986

PCA Derivation Sample
20 NC

0.000 ± 0.099

0.000 ± 0.096

0.000 ± 0.096

0.000 ± 0.097

*
20 PD

1.486 ± 0.186

1.473 ± 0.190

1.471 ± 0.191

1.469 ± 0.191

AUC (CI)

0.993 (0.974, 1.011)

0.985 (0.959, 1.011)

0.985 (0.959, 1.011)

0.984 (0.956, 1.012)

Sensitivity

0.95

0.90

0.90

0.90

Specificity

0.95

0.90

0.90

0.90

TPR Validation Sample
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13 NC

0.000 ± 0.118

0.000 ± 0.117

0.000 ± 0.117

0.000 ± 0.117

*
13 PD

1.462 ± 0.239

1.436 ± 0.246

1.434 ± 0.247

1.434 ± 0.247

AUC (CI)

0.970 (0.914, 1.027)

0.959 (0.892, 1.025)

0.959 (0.892, 1.025)

0.959 (0.892, 1.025)

Sensitivity

0.92

0.85

0.85

0.85

Specificity

0.92

0.92

0.92

0.92

Subject Score Correlation

a

20 NC

1.000

0.972

0.971

0.971

20 PD

1.000

0.995

0.995

0.995

13 NC

1.000

0.966

0.968

0.969

13 PD

1.000

0.995

0.996

0.996

All average values are given as mean ± SE.
VAF = variance accounted for in principal component analysis
GIS = Group Invariant Subprofile from the derivation sample of PD and control subjects.
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The correlations of the GIS weights were performed over a standard 30 VOI template with a threshold of 80 % or over all voxels of the brain with
non-zero values.
AUC = area under the curve in the receiver operating characteristic analysis
CI = 95% confidence of intervals (lower bound, upper bound)
Sensitivity = true positive rate (TPR)
Specificity = true negative rate (TNR)
*

p < 0.0001 with respect to normal controls (Student's unpaired t-tests)

a

p < 0.0001 Pearson correlation coefficient from regression analysis

Hum Brain Mapp. Author manuscript; available in PMC 2015 May 01.

Peng et al.

Page 23

Table III

NIH-PA Author Manuscript

Comparisons of PDCP network and subject scores with FDG PET images normalized by four versions of SPM
software
SPM99
VAF (%)
d

GIS weights

SPM2

SPM5

SPM8

19.28

20.92

20.65

20.81

1.000/1.000

0.976/0.949

0.968/0.940

0.970/0.943

0.640 ± 0.325

0.608 ± 0.326

0.617 ± 0.325

PCA Derivation Sample
15 PD
CVLT

0.864 ± 0.312
c

-0.727

b

b

b

-0.661

-0.645

-0.650

0.883 ± 0.225

0.851 ± 0.222

0.856 ± 0.222

TPR Validation Sample
15 PD
CVLT
CVLT 30 PD

1.087 ± 0.236
a

-0.503

d

-0.650

NIH-PA Author Manuscript

Subject Score Correlation

a

-0.610

d

a

-0.612

d

a

-0.610

d

-0.642

-0.632

-0.635

d

15 PD

1.000

0.965

0.957

0.959

15 NC

1.000

0.948

0.947

0.952

15 PD2

1.000

0.975

0.970

0.973

All average values are given as mean ± SE.
VAF = variance accounted for in principal component analysis
GIS = Group Invariant Subprofile from the derivation sample of PD patients.
The correlations of the GIS weights were performed over a standard 30 VOI template with a threshold of 80 % or over all voxels of the brain with
non-zero values.
a

p < 0.05

b

p < 0.01

c

p < 0.005

d

p < 0.0001 Pearson correlation coefficient from regression analysis
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Table IV

Subject scores of PDRP and PDCP networks with FDG images from multiple PET scanners
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PDRP

PDCP

Site (No.)

SPM99

SPM5

SPM99

SPM5

All (n=23)

1.23 ± 0.14

1.27 ± 0.15

1.08 ± 0.14

0.84 ± 0.13

Site A (n=10)

1.07 ± 0.21

1.13 ± 0.22

1.02 ± 0.19

0.83 ± 0.19

Others (n=13)

1.36 ± 0.19

1.38 ± 0.21

1.12 ± 0.21

0.84 ± 0.19

All average values are given as mean ± SE.
Subject scores were computed using multicenter FDG PET images normalized by two different versions of SPM software.
Scanner information for all participating sites is available in Suppl. Table I.
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